BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16410722)

  • 1. Connecting p63 to cellular proliferation: the example of the adenosine deaminase target gene.
    Sbisà E; Mastropasqua G; Lefkimmiatis K; Caratozzolo MF; D'Erchia AM; Tullo A
    Cell Cycle; 2006 Jan; 5(2):205-12. PubMed ID: 16410722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p63 and p73 transactivate differentiation gene promoters in human keratinocytes.
    De Laurenzi V; Rossi A; Terrinoni A; Barcaroli D; Levrero M; Costanzo A; Knight RA; Guerrieri P; Melino G
    Biochem Biophys Res Commun; 2000 Jun; 273(1):342-6. PubMed ID: 10873608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 target.
    Tullo A; Mastropasqua G; Bourdon JC; Centonze P; Gostissa M; Costanzo A; Levrero M; Del Sal G; Saccone C; Sbisà E
    Oncogene; 2003 Nov; 22(54):8738-48. PubMed ID: 14647469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-binding and transactivation activities are essential for TAp63 protein degradation.
    Ying H; Chang DL; Zheng H; McKeon F; Xiao ZX
    Mol Cell Biol; 2005 Jul; 25(14):6154-64. PubMed ID: 15988026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
    DeYoung MP; Johannessen CM; Leong CO; Faquin W; Rocco JW; Ellisen LW
    Cancer Res; 2006 Oct; 66(19):9362-8. PubMed ID: 17018588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fatty acid synthase gene is a conserved p53 family target from worm to human.
    D'Erchia AM; Tullo A; Lefkimmiatis K; Saccone C; Sbisà E
    Cell Cycle; 2006 Apr; 5(7):750-8. PubMed ID: 16582625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the p53 family of proteins in central and peripheral human corneal endothelial cells.
    Paull AC; Whikehart DR
    Mol Vis; 2005 May; 11():328-34. PubMed ID: 15889017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species.
    Ellisen LW; Ramsayer KD; Johannessen CM; Yang A; Beppu H; Minda K; Oliner JD; McKeon F; Haber DA
    Mol Cell; 2002 Nov; 10(5):995-1005. PubMed ID: 12453409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated ΔNp63α negatively regulates the maspin promoter in keratinocytes via blocking endogenous p73 binding.
    King KE; Reddi DM; Ponnamperuma RM; Gerdes M; Weinberg WC
    Mol Carcinog; 2014 Sep; 53(9):698-710. PubMed ID: 23475637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential recognition of response elements determines target gene specificity for p53 and p63.
    Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
    Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.
    Helton ES; Zhu J; Chen X
    J Biol Chem; 2006 Feb; 281(5):2533-42. PubMed ID: 16319057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.
    Spiesbach K; Tannapfel A; Mössner J; Engeland K
    Int J Cancer; 2005 Apr; 114(4):555-62. PubMed ID: 15578720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
    Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
    J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p63 regulates proliferation and differentiation of developmentally mature keratinocytes.
    Truong AB; Kretz M; Ridky TW; Kimmel R; Khavari PA
    Genes Dev; 2006 Nov; 20(22):3185-97. PubMed ID: 17114587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent alteration of p63 expression in human primary bladder carcinomas.
    Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
    Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DeltaNp63 antagonizes p53 to regulate mesoderm induction in Xenopus laevis.
    Barton CE; Tahinci E; Barbieri CE; Johnson KN; Hanson AJ; Jernigan KK; Chen TW; Lee E; Pietenpol JA
    Dev Biol; 2009 May; 329(1):130-9. PubMed ID: 19272371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner.
    Yan W; Chen X
    J Biol Chem; 2006 Mar; 281(12):7856-62. PubMed ID: 16446369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical interaction with human tumor-derived p53 mutants inhibits p63 activities.
    Strano S; Fontemaggi G; Costanzo A; Rizzo MG; Monti O; Baccarini A; Del Sal G; Levrero M; Sacchi A; Oren M; Blandino G
    J Biol Chem; 2002 May; 277(21):18817-26. PubMed ID: 11893750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63.
    Bernassola F; Oberst A; Melino G; Pandolfi PP
    Oncogene; 2005 Oct; 24(46):6982-6. PubMed ID: 16007146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8.
    Chakravarti D; Su X; Cho MS; Bui NH; Coarfa C; Venkatanarayan A; Benham AL; Flores González RE; Alana J; Xiao W; Leung ML; Vin H; Chan IL; Aquino A; Müller N; Wang H; Cooney AJ; Parker-Thornburg J; Tsai KY; Gunaratne PH; Flores ER
    Proc Natl Acad Sci U S A; 2014 Feb; 111(5):E572-81. PubMed ID: 24449888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.